Hypoxic-Ischaemic Encephalopathy Completed Phase 1 Trials for Erythropoietin (DB00016)

Also known as: Encephalopathy, Hypoxic-Ischemic / Hypoxic-Ischemic Encephalopathy / Hypoxic ischemic encephalopathy [HIE], unspecified / Hypoxic ischemic brain injury

IndicationStatusPhase
DBCOND0080116 (Hypoxic-Ischaemic Encephalopathy)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00719407Neonatal Erythropoietin in Asphyxiated Term NewbornsTreatment